{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:02:39Z","timestamp":1785416559930,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tobacco heating products (THPs) have reduced emissions of toxicants compared with cigarette smoke, and as they expose user to lower levels than smoking, have for a role to play in tobacco harm reduction. One key concern of Public Health is that new tobacco and nicotine products should not be more addictive than cigarettes. To assess their abuse liability, we determined nicotine pharmacokinetics and subjective effects of two THPs compared with conventional cigarettes and a nicotine replacement therapy (Nicotine inhaler). In a randomised, controlled, open-label, crossover study healthy adult smokers used a different study product in a 5\u00a0min ad libitum use session in each of four study periods. Product liking, overall intent to use again, urge for product and urge to smoke questionnaires were utilised to assess subjective effects. Nicotine uptake was greater for the cigarette (C<jats:sub>max<\/jats:sub>\u2009=\u200922.7\u00a0ng\/mL) than for either THP (8.6 and 10.5\u00a0ng\/mL) and the NRT (2.3\u00a0ng\/mL). Median T<jats:sub>max<\/jats:sub> was significantly longer for the NRT (15.03\u00a0min) than for the tobacco products (4.05\u20136.03\u00a0min). Product liking and overall intent to use again was highest for the cigarette, and higher for the THPs than the NRT. Urge to smoke was reduced more by the cigarette than by the other three products. Urge to use the THPs was greater than the NRT. These findings suggest that the abuse liability of the THPs lies between that of subjects usual brand cigarettes and the NRT.<\/jats:p>","DOI":"10.1038\/s41598-022-19167-8","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:04:09Z","timestamp":1661803449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy"],"prefix":"10.1038","volume":"12","author":[{"given":"George","family":"Hardie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Milleri","family":"Oscar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ziviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"19167_CR1","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"NL Benowitz","year":"2010","unstructured":"Benowitz, N. L. Nicotine addiction. N. Engl. J. Med. 362, 2295\u20132303 (2010).","journal-title":"N. Engl. J. Med."},{"key":"19167_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098614524430","volume":"5","author":"KE Farsalinos","year":"2014","unstructured":"Farsalinos, K. E. & Polosa, R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Ther. Adv. Drug Saf. 5, 67\u201386 (2014).","journal-title":"Ther. Adv. Drug Saf."},{"key":"19167_CR3","unstructured":"National Center For Chronic Disease Prevention And Health Promotion (Us) Office On Smoking And Health. The Health Consequences Of Smoking- 50 Years Of Progress: A Report Of The Surgeon General. (Centers For Disease Control And Prevention (Us), 2014)."},{"key":"19167_CR4","unstructured":"Rodgman, A. & Perfetti, T. A. The Chemical Components Of Tobacco And Tobacco Smoke, Second Edition. (Taylor & Francis Group, 2013)."},{"key":"19167_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/tc.12.4.424","volume":"12","author":"J Fowles","year":"2003","unstructured":"Fowles, J. & Dybing, E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control. 12, 424\u2013430 (2003).","journal-title":"Tob. Control."},{"key":"19167_CR6","first-page":"20034","volume":"77","author":"FAD Administration","year":"2012","unstructured":"United States & Administration, F. A. D. Harmful and potentially harmful constituents in tobacco products and tobacco smoke established list. Fed. Reg. 77, 20034\u201320037 (2012).","journal-title":"Fed. Reg."},{"key":"19167_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","volume":"32","author":"R Polosa","year":"2011","unstructured":"Polosa, R. & Benowitz, N. L. Treatment of nicotine addiction: Present therapeutic options and pipeline developments. Trends Pharmacol. Sci. 32, 281\u2013289 (2011).","journal-title":"Trends Pharmacol. Sci."},{"key":"19167_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200140090-00003","volume":"40","author":"NG Schneider","year":"2001","unstructured":"Schneider, N. G., Olmstead, R. E., Franzon, M. A. & Lunell, E. The nicotine inhaler: Clinical pharmacokinetics and comparison with other nicotine treatments. Clin. Pharmacokinet. 40, 661\u2013684 (2001).","journal-title":"Clin. Pharmacokinet."},{"key":"19167_CR9","first-page":"811","volume":"7","author":"J Le Houezec","year":"2003","unstructured":"Le Houezec, J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review. Int. J. Tuberc. Lung Dis. 7, 811\u2013819 (2003).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"19167_CR10","first-page":"425","volume":"10","author":"U Wadgave","year":"2016","unstructured":"Wadgave, U. & Nagesh, L. Nicotine Replacement therapy: An overview. Int. J. Health Sci. (Qassim) 10, 425\u2013435 (2016).","journal-title":"Int. J. Health Sci. (Qassim)"},{"key":"19167_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s002280050007","volume":"55","author":"E Lunell","year":"2000","unstructured":"Lunell, E., Molander, L., Ekberg, K. & Wahren, J. Site of nicotine absorption from a vapour inhaler\u2014Comparison with cigarette smoking. Eur. J. Clin. Pharmacol. 55, 737\u2013741 (2000).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"19167_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ntr\/nts123","volume":"15","author":"H Digard","year":"2013","unstructured":"Digard, H., Proctor, C., Kulasekaran, A., Malmqvist, U. & Richter, A. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob. Res. 15, 255\u2013261 (2013).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR13","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00213-017-4665-y","volume":"234","author":"MF Stiles","year":"2017","unstructured":"Stiles, M. F. et al. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: Implications for abuse liability. Psychopharmacology 234, 2643\u20132655 (2017).","journal-title":"Psychopharmacology"},{"key":"19167_CR14","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00213-018-4904-x","volume":"235","author":"MF Stiles","year":"2018","unstructured":"Stiles, M. F. et al. Assessment of the abuse liability of three menthol vuse solo electronic cigarettes relative to combustible cigarettes and nicotine gum. Psychopharmacology 235, 2077\u20132086 (2018).","journal-title":"Psychopharmacology"},{"key":"19167_CR15","doi-asserted-by":"publisher","unstructured":"Barbeau, A. M., Burda, J., & Siegel, M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: A qualitative approach. Addict. Sci. Clin. Pract. 8(1), 5. https:\/\/doi.org\/10.1186\/1940-0640-8-5 (2013).","DOI":"10.1186\/1940-0640-8-5"},{"key":"19167_CR16","doi-asserted-by":"publisher","unstructured":"Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C. & Lancaster, T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst. Rev. 5, Cd000146. https:\/\/doi.org\/10.1002\/14651858.Cd000146.Pub5 (2018).","DOI":"10.1002\/14651858.Cd000146.Pub5"},{"key":"19167_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","volume":"192","author":"NL Benowitz","year":"2009","unstructured":"Benowitz, N. L., Hukkanen, J. & Jacob, P. 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 192, 29\u201360 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"19167_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/tc.10.2.189","volume":"10","author":"K Stratton","year":"2001","unstructured":"Stratton, K., Shetty, P., Wallace, R. & Bondurant, S. Clearing the smoke: the science base for tobacco harm reduction\u2014Executive summary. Tob. Control. 10, 189\u2013195 (2001).","journal-title":"Tob. Control."},{"key":"19167_CR19","unstructured":"Royal College Of Physicians. Nicotine Without Smoke. Tobacco Harm Reduction. A Report By The Tobacco Advisory Group Of The Royal College Of Physicians. (Rcp, 2016)."},{"key":"19167_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.yrtph.2017.09.009","volume":"93","author":"P Design","year":"2018","unstructured":"Design, P. et al. Assessment of tobacco heating product Thp1.0. Part 2. Regul. Toxicol. Pharmacol. 93, 4\u201313 (2018).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"19167_CR21","doi-asserted-by":"crossref","unstructured":"Schaller, J-P. Et Al. Evaluation of the tobacco heating system 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul. Toxicol. Pharmacol. 81 Suppl 2, S27-S47 (2016).","DOI":"10.1016\/j.yrtph.2016.10.001"},{"key":"19167_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yrtph.2017.10.006","volume":"93","author":"CCCOHAPH Aerosol","year":"2018","unstructured":"Aerosol, C. C. C. O. H. A. P. H. et al. Assessment of novel tobacco heating product Thp1.0. Part 3. Regul. Toxicol. Pharmacol. 93, 14\u201333 (2018).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"19167_CR23","doi-asserted-by":"crossref","unstructured":"Jaunky, T. Et Al. Assessment of tobacco heating product Thp1.0. Part 5: In vitro dosimetric and cytotoxic assessment. Regul. Toxicol. Pharmacol. 93, 52\u201361 (2018).","DOI":"10.1016\/j.yrtph.2017.09.016"},{"key":"19167_CR24","doi-asserted-by":"crossref","unstructured":"Taylor, M. Et Al. Assessment of novel tobacco heating product Thp1.0. Part 6: A comparative in vitro study using contemporary screening approaches. Regul. Toxicol. Pharmacol. 93, 62\u201370 (2018).","DOI":"10.1016\/j.yrtph.2017.08.016"},{"key":"19167_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yrtph.2017.08.017","volume":"93","author":"Comparative In Vitro Toxicological Evaluation","year":"2018","unstructured":"Comparative In Vitro Toxicological Evaluation. Thorne, D., Breheny, D., Proctor, C. & Gaca, M. Assessment of novel tobacco heating product Thp1.0. Part 7. Regul. Toxicol. Pharmacol. 93, 71\u201383 (2018).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"19167_CR26","doi-asserted-by":"publisher","unstructured":"Beatrice, F. & Massaro, G. Exhaled carbon monoxide levels in forty resistant to cessation male smokers after six months of full switch to electronic cigarettes (E-Cigs) or to a tobacco heating systems (Ths). Int. J. Environ. Res. Public Health. 16, 3916. https:\/\/doi.org\/10.3390\/Ijerph16203916 (2019).","DOI":"10.3390\/Ijerph16203916"},{"key":"19167_CR27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/ntr\/nty104","volume":"21","author":"N Gale","year":"2019","unstructured":"Gale, N. et al. Changes In biomarkers of exposure on switching from a conventional cigarette to tobacco heating products: A randomized, controlled study in healthy Japanese subjects. Nicotine Tob. Res. 21, 1220\u20131227 (2019).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/S11739-021-02798-6","author":"N Gale","year":"2021","unstructured":"Gale, N. et al. Changes in biomarkers after 180 days of tobacco heating product use: A randomised trial. Intern. Emerg. Med. https:\/\/doi.org\/10.1007\/S11739-021-02798-6 (2021).","journal-title":"Intern. Emerg. Med."},{"key":"19167_CR29","doi-asserted-by":"crossref","unstructured":"Haziza, C. Et Al. Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for three months (Part 1). Nicotine Tob. Res. 22, 539\u2013548 (2019).","DOI":"10.1093\/ntr\/ntz013"},{"key":"19167_CR30","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1158\/1055-9965.EPI-18-0915","volume":"28","author":"F L\u00fcdicke","year":"2019","unstructured":"L\u00fcdicke, F. et al. Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: A randomized trial. Cancer Epidemiol. Biomarkers Prev. 28, 1934\u20131943 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"19167_CR31","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1158\/1055-9965.EPI-09-0948","volume":"18","author":"LP Carter","year":"2009","unstructured":"Carter, L. P. et al. Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol. Biomarkers Prev. 18, 3241\u20133262 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"19167_CR32","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/1055-9965.EPI-10-0288","volume":"19","author":"AR Vansickel","year":"2010","unstructured":"Vansickel, A. R., Cobb, C. O., Weaver, M. F. & Eissenberg, T. E. A clinical laboratory model for evaluating the acute effects of electronic \u201ccigarettes\u201d: Nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev. 19, 1945\u20131953 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"19167_CR33","unstructured":"United States, Food and drug administration. Premarket tobacco product applications for electronic nicotine delivery systems (Ends). Guidance for industry. https:\/\/www.fda.gov\/media\/127853\/download (2019)."},{"key":"19167_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1037\/0022-006X.61.5.743","volume":"61","author":"JE Henningfield","year":"1993","unstructured":"Henningfield, J. E. & Keenan, R. M. Nicotine delivery kinetics and abuse liability. J. Consult. Clin. Psychol. 61, 743\u2013750 (1993).","journal-title":"J. Consult. Clin. Psychol."},{"key":"19167_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","volume":"49","author":"NL Benowitz","year":"2009","unstructured":"Benowitz, N. L. Pharmacology of nicotine: addiction, smoking-induced disease and therapeutics. Annu. Rev. Pharmacol. Toxicol. 49, 57\u201371 (2009).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"19167_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.12.009","volume":"116","author":"JE Henningfield","year":"2011","unstructured":"Henningfield, J. E., Hatsukami, D. K., Zeller, M. & Peters, E. Conference on abuse liability and appeal of tobacco products: conclusions and recommendations. Drug Alcohol Depend. 116, 1\u20137 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"19167_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.yrtph.2015.12.004","volume":"74","author":"SAS Effects","year":"2016","unstructured":"Effects, S. A. S. Walele, T., Sharma, G., Savioz, R., Martin, C. & Williams, J. A Randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B. Regul. Toxicol. Pharmacol. 74, 193\u2013199 (2016).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"19167_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/pha0000261","volume":"27","author":"SF Maloney","year":"2019","unstructured":"Maloney, S. F. et al. Abuse liability assessment of an electronic cigarette in combustible cigarette smokers. Exp. Clin. Psychopharmacol. 27, 443\u2013454 (2019).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"19167_CR39","doi-asserted-by":"publisher","unstructured":"Goldenson, N. I., Buchhalter, A. R., Augustson, E. M., Rubinstein, M. L. & Henningfield, J. E. Abuse liability assessment of the juul system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers. Drug Alcohol Depend. 217, 108395. https:\/\/doi.org\/10.1016\/J.Drugalcdep.2020.108395 (2020).","DOI":"10.1016\/J.Drugalcdep.2020.108395"},{"key":"19167_CR40","doi-asserted-by":"publisher","unstructured":"Goldenson, N. I. Et Al. Abuse liability assessment of the juul system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system. Drug Alcohol Depend. 217, 108441. https:\/\/doi.org\/10.1016\/J.Drugalcdep.2020.108441 (2020).","DOI":"10.1016\/J.Drugalcdep.2020.108441"},{"key":"19167_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/ntr\/ntv220","volume":"18","author":"P Picavet","year":"2016","unstructured":"Picavet, P., Haziza, C., Lama, N., Weitkunat, R. & L\u00fcdicke, F. comparison of the pharmacokinetics of nicotine following single and ad libitum use of a tobacco heating system or combustible cigarettes. Nicotine Tob. Res. 18, 557\u2013563 (2016).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR42","doi-asserted-by":"crossref","unstructured":"Brossard, P. Et Al. Nicotine pharmacokinetic profiles of the tobacco heating system 2.2, cigarettes and nicotine gum in Japanese smokers. Regul. Toxicol. Pharmacol. 89, 193\u2013199 (2017).","DOI":"10.1016\/j.yrtph.2017.07.032"},{"key":"19167_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0269881112458731","volume":"27","author":"A Mcneill","year":"2013","unstructured":"Mcneill, A. & Munaf\u00f2, M. R. Reducing harm from tobacco use. J. Psychopharmacol. 27, 13\u201318 (2013).","journal-title":"J. Psychopharmacol."},{"key":"19167_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-publhealth-040617-013849","volume":"39","author":"DB Abrams","year":"2018","unstructured":"Abrams, D. B. et al. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu. Rev. Public Health. 39, 193\u2013213 (2018).","journal-title":"Annu. Rev. Public Health."},{"key":"19167_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ypmed.2018.06.010","volume":"117","author":"DB Abrams","year":"2018","unstructured":"Abrams, D. B. et al. Managing nicotine without smoke to save lives now: evidence for harm minimization. Prev. Med. 117, 88\u201397 (2018).","journal-title":"Prev. Med."},{"key":"19167_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ntr\/nty200","volume":"21","author":"M Zeller","year":"2019","unstructured":"Zeller, M. The future of nicotine regulation: Key questions and challenges. Nicotine Tob. Res. 21, 331\u2013332 (2019).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR47","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/ntr\/nts007","volume":"14","author":"K Fagerstr\u00f6m","year":"2012","unstructured":"Fagerstr\u00f6m, K. & Eissenberg, T. Dependence on tobacco and nicotine products: A case for product-specific assessment. Nicotine Tob. Res. 14, 1382\u20131390 (2012).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11739-019-02090-8","volume":"14","author":"N Newland","year":"2019","unstructured":"Newland, N. et al. Evaluating the effects of switching from cigarette smoking to using a heated tobacco product on health effect indicators in healthy subjects: Study protocol for a randomized controlled trial. Intern. Emerg. Med. 14, 885\u2013898 (2019).","journal-title":"Intern. Emerg. Med."},{"key":"19167_CR49","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/ntr\/nts265","volume":"15","author":"DK Hatsukami","year":"2013","unstructured":"Hatsukami, D. K., Zhang, Y., O\u2019connor, R. J. & Severson, H. H. Subjective responses to oral tobacco products: scale validation. Nicotine Tob. Res. 15, 1259\u20131264 (2013).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR50","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ntr\/ntaa190","volume":"23","author":"Z Cahn","year":"2021","unstructured":"Cahn, Z. et al. Applying the population health standard to the regulation of electronic nicotine delivery systems. Nicotine Tob. Res. 23, 780\u2013789 (2021).","journal-title":"Nicotine Tob. Res."},{"key":"19167_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cpdd.909","volume":"10","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Characterization of the abuse potential in adult smokers of a novel oral tobacco product relative to combustible cigarettes and nicotine polacrilex gum. Clin. Pharmacol. Drug Dev. 10, 241\u2013250 (2021).","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"19167_CR52","doi-asserted-by":"publisher","unstructured":"Adamson, J. Et Al. Results from a 2018 cross-sectional survey In Tokyo, Osaka and Sendai to assess tobacco and nicotine product usage after the introduction of heated tobacco products (Htps) in Japan. Harm Reduct. J. 17, 32. https:\/\/doi.org\/10.1186\/S12954-020-00374-3 (2020).","DOI":"10.1186\/S12954-020-00374-3"}],"updated-by":[{"DOI":"10.1038\/s41598-023-37432-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19167-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19167-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19167-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T17:05:31Z","timestamp":1687885531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19167-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19167-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-37432-2","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"24 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-37432-2","URL":"https:\/\/doi.org\/10.1038\/s41598-023-37432-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14701"}}